Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
BEAR ERIC X4S N1	BEAR ERICSSON X	Nasdaq Stockholm	-	39.18 SEK	Certificat
BEAR ERIC X5S N1	BEAR ERICSSON X	Nasdaq Stockholm	0	15.66 SEK	Certificat
BEAR ERIC X2 H2	BEAR ERIC X2 H2	Nasdaq Stockholm	0	18.32 SEK	Certificat
BULL ERIC X2 H2	BULL ERIC X2 H2	Nasdaq Stockholm	0	16.66 SEK	Certificat

News (105)

RB Global : Conference Presentation	05-16	PU
Transcript : RB Global, Inc., Q1 2024 Earnings Call, May 09, 2024	05-09
RB Global reports first quarter 2024 results	05-09	PR
Transcript : Nexans S.A., Q1 2024 Earnings Call, Apr 24, 2024	04-24
Transcript : RB Global, Inc., Q4 2023 Earnings Call, Feb 23, 2024	02-23
RB Global reports fourth quarter and full year 2023 results	02-23	PR
RB Global, Inc. Announces Executive Changes	02-02	CI
RB Global names Eric Guerin as CFO	12-12	RE
RB Global, Inc. Appoints Eric J. Guerin as Chief Financial Officer, Effective January 15, 2024	12-12	CI
RB Global Appoints Eric J. Guerin as Chief Financial Officer	12-12	PR
Veritiv Corporation Announces Board Changes	11-30	CI
Transcript : Nexans S.A., Q3 2023 Earnings Call, Oct 25, 2023	25/10/23
Veritiv Announces Second Quarter 2023 Financial Results	08/08/23	PR
Transcript : Nexans S.A., H1 2023 Earnings Call, Jul 26, 2023	26/07/23
Transcript : Veritiv Corporation, Q1 2023 Earnings Call, May 09, 2023	09/05/23
Veritiv Announces First Quarter 2023 Financial Results, Reaffirms 2023 Guidance	09/05/23	PR
Transcript : Veritiv Corporation - Shareholder/Analyst Call	03/05/23
Moderna, Inc.	06/04/23	AQ
Transcript : Veritiv Corporation, Q4 2022 Earnings Call, Feb 28, 2023	28/02/23
Transcript : Bouygues SA - Analyst/Investor Day	23/02/23
Merck : Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA® (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Melanoma Following Complete Resection	22/02/23	PU
VERITIV CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	08/12/22	AQ
Veritiv Announces CFO Transition	08/12/22	PR
Veritiv Corporation Announces Management Changes	08/12/22	CI
Veritiv Corporation Announces CFO Transition	08/12/22	CI
Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII	27/09/22	GL
Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII	27/09/22	AQ
Transcript : Nexans S.A., H1 2022 Earnings Call, Jul 27, 2022	27/07/22
CDK GLOBAL, INC. : Change in Directors or Principal Officers (form 8-K)	12/07/22	AQ
CDK Global, Inc. Announces Resignation of Eric Guerin as Chief Financial Officer on July 22, 2022	12/07/22	CI
NATUS MEDICAL INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	15/06/22	AQ
Merck to Hold Investor Event to Highlight Oncology Portfolio and Pipeline	07/06/22	BU
Galapagos : to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress - Form 6-K	31/05/22	PU
Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress	25/05/22	GL
SKYWORKS SOLUTIONS, INC. Submission of Matters to a Vote of Security Holders (form 8-K/A)	16/05/22	AQ
SKYWORKS SOLUTIONS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	13/05/22	AQ
SKYWORKS SOLUTIONS, INC. Change in Directors or Principal Officers (form 8-K/A)	13/05/22	AQ
Transcript : Compagnie Générale des Établissements Michelin Société en commandite par actions - Shareholder/Analyst Call	13/05/22
Transcript : CDK Global, Inc., Q2 2022 Earnings Call, Feb 03, 2022	03/02/22
CDK GLOBAL : REPORTS SECOND QUARTER FISCAL 2022 RESULTS - Form 8-K	03/02/22	PU
CDK Global, Inc. Reports Second Quarter Fiscal 2022 Results	03/02/22	GL
SKYWORKS SOLUTIONS, INC. : Change in Directors or Principal Officers (form 8-K)	02/02/22	AQ
Skyworks Appoints Eric Guerin to its Board of Directors	31/01/22	BU
Skyworks Solutions, Inc. Appoints Eric Guerin to Its Board of Directors	31/01/22	CI
CDK Global to Announce Second Quarter Fiscal Year 2022 Financial Results on February 3, 2022	19/01/22	AQ

123NextSee all

Companies (5)

CHEYENNE RESOURCES CORPORATION 55 $

Cheyenne Resources Corp. is focused on developing shallow natural gas and oil wells in Northeastern Oklahoma. The Company is an independent energy development firm primarily engaged in the exploration, development, and production of oil and natural gas. T ...

ONLINE BRANDS NORDIC AB 30 M $

Online Brands Nordic AB, formerly Onskefoto AB, is a Sweden-based company engaged in the jewelry sector. The Company operates online shops with jewelry made primarily of gold and silver, namely hedbergsguld.se and jewel.se, as well as operates a shop in D ...

SIBANNAC, INC. 898 029 $

Sibannac, Inc. is engaged in creating and selling premium next generation wellness products in the consumer packaging goods space. The Company specializes in creating and selling premium Cannabidiol (CBD) products. In addition to mainstream supplements, t ...

ENGENE HOLDINGS INC. 567 M $

enGene Holdings Inc. is a holding company. The Company, through its subsidiary, enGene Inc., is engaged in developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues. The Companyâs proprietary dually deri ...

VACCINOGEN INC - $

Vaccinogen, Inc. is a biotechnology company. The Company is the developer of OncoVAX. OncoVAX is an active specific immunotherapy (ASI) that uses the patient's own cancer cells to create a vaccine that in turn is used to block the return of cancer followi ...

Insiders

Eric Guerin

Eric J.
Guerin is currently an Independent Director at Skyworks Solutions, Inc., Chief Financial Officer, Director & Senior VP at Veritiv Corp., and Chief Financial Officer at RB Global, Inc. Previously, he served as an Independent Director at Natus Medical, Inc., CFO-Aftermarket Services & Vice President-Finance at Flowserve Corp., Vice President-Finance Division at Corning, Inc., and Chief Financial Officer & Executive Vice President at CDK Global, Inc. Mr. Guerin holds an undergraduate degree from The College of Staten Island and an MBA from St. John's University.

Claude Guerin is currently working as a Fund Manager at BNP Paribas Asset Management Europe SAS.

No results for this search